| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/08/1999 | EP0643716B1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 12/08/1999 | EP0543997B1 Derivatives of methotrexate with antirheumatic activity |
| 12/08/1999 | EP0522078B1 Gp75 as a tumor vaccine for melanoma |
| 12/08/1999 | CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use |
| 12/08/1999 | CN1237975A Ethylenediaminetriacetic acid and N-acyl ethylenediaminetriacetic acid silver chelactants |
| 12/08/1999 | CN1237974A Process for producing ecteinascidin compounds |
| 12/08/1999 | CN1237971A 2-carbonylthiazole derivatives and use of the same |
| 12/08/1999 | CN1237970A Epothilone C. D. E and F, production process, and their use as cytostatic as well as phytosanitary agents |
| 12/08/1999 | CN1237969A Multivalent salts of pyridostigmine and related compounds |
| 12/08/1999 | CN1237963A Qinoline derivatives inhibiting effect of growth factors such as VEGF |
| 12/08/1999 | CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 12/08/1999 | CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 12/08/1999 | CN1237960A N (aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds |
| 12/08/1999 | CN1237958A New manufacturing process of metoprolol |
| 12/08/1999 | CN1237955A Substituted phenols and thiophenols useful as antioxidant agents |
| 12/08/1999 | CN1237910A Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 12/08/1999 | CN1237908A Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| 12/08/1999 | CN1237907A Formulation for electrically assisted delivery of lidocaine and epinephrine |
| 12/08/1999 | CN1237906A New use for 1,3-propanediol derivatives |
| 12/08/1999 | CN1237905A Use of sibutramine analogues to prevent development of diabetes |
| 12/08/1999 | CN1237904A New use of creatine |
| 12/08/1999 | CN1237903A Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 12/08/1999 | CN1237901A Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
| 12/08/1999 | CN1237897A Skin care compositions containing acid and retinoid |
| 12/08/1999 | CN1237881A Method and compositions for increasing anaerobic working capacity in tissues |
| 12/08/1999 | CN1237583A Steroid saponins compound for curing cancer and its preparation method |
| 12/08/1999 | CN1237581A Compound for curing AIDS and its preparation method |
| 12/08/1999 | CN1237580A Phosphononooxymethyl ethers of taxame derivatives |
| 12/08/1999 | CN1237439A New process for extracting danshensu from red sage root and protocatechualdehyde |
| 12/08/1999 | CN1237432A Chinese medicine chive buld composite for improving hyperlipemia |
| 12/08/1999 | CN1237419A Pharmaceutical process of crocus sativus polyglycoside and its tablet |
| 12/08/1999 | CN1237418A Pain-alleviating medicine xuecaosu and its preparation method |
| 12/08/1999 | CN1237417A Controlled drug delivery system for diltiazem |
| 12/08/1999 | CN1237416A Compound piperaquine tablet |
| 12/08/1999 | CN1237415A Stable oral pharmaceutical composition containing substituted pyridylsulfinyl benzimidazole |
| 12/08/1999 | CN1047171C Method for preparing 1,2-dithiol-3-thion-S-oxid-compound pharmaceutical |
| 12/08/1999 | CN1047169C Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives, and its use and medicinal preparation |
| 12/08/1999 | CN1047168C (S)-a-phenyl-2-pyridineethanamine(s)-malate, and its preparing method and use |
| 12/08/1999 | CN1047162C Acetylglutaminylzinc compound and its preparation and usage |
| 12/08/1999 | CN1047077C Stable painless piroxicam potassium injectable composition |
| 12/08/1999 | CN1047076C Stabilized injection and method of stabilizing injection |
| 12/08/1999 | CN1047075C Bisacodyl dosage form |
| 12/08/1999 | CN1047074C Erythromycin capsule for silkworm |
| 12/07/1999 | US5998666 Phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 12/07/1999 | US5998665 Therapy for nervous system disorders |
| 12/07/1999 | US5998648 Anticancer (IV) complexes for oral administration and a method of making the same |
| 12/07/1999 | US5998642 Thienyl-containing fatty acid glycosyl phosphatidylinosital analogues used for inhibiting parasitic activity |
| 12/07/1999 | US5998638 Ester salt of 5α-pregn-16-en-3β-ol-20-one 3-sulfate |
| 12/07/1999 | US5998630 A 1-(3-(1-pyrrolidinyl)propy)-3-ethylcarbodiimide |
| 12/07/1999 | US5998622 Analgesics; antiinflammatory agents; side effect reduction |
| 12/07/1999 | US5998615 Alzheimer's disease; nervous system disorders |
| 12/07/1999 | US5998613 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
| 12/07/1999 | US5998605 Antiviral benzimidazole nucleoside analogues and method for their preparation |
| 12/07/1999 | US5998602 RNase L activators and antisense oligonucleotides effective to treat RSV infections |
| 12/07/1999 | US5998600 β-catenin, TCF-4, and APC interact to prevent cancer |
| 12/07/1999 | US5998588 Interactive molecular conjugates |
| 12/07/1999 | US5998583 BH3 interacting domain death agonist |
| 12/07/1999 | US5998487 Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions |
| 12/07/1999 | US5998486 Treatment of emphysema with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli) |
| 12/07/1999 | US5998485 Dose dependent |
| 12/07/1999 | US5998482 Use of synthetic polycationic amphiphilic substances with fatty acid or hydrocarbon substituents as anti-sepsis agents |
| 12/07/1999 | US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 12/07/1999 | US5998480 Pharmaceutical preparation containing nimesulide for topical use |
| 12/07/1999 | US5998479 Method of treating adult respiratory syndrome |
| 12/07/1999 | US5998478 Timed release tablet comprising naproxen and pseudoephedrine |
| 12/07/1999 | US5998477 Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions |
| 12/07/1999 | US5998476 Reaction product of unsaturated fatty acid with glycine or aspartic acid |
| 12/07/1999 | US5998475 Nontoxic to humans, animals; biodegradable |
| 12/07/1999 | US5998474 Reduction of oxygen free radicals; nervous system disorders,cardiovascular disorders |
| 12/07/1999 | US5998473 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester derivatives |
| 12/07/1999 | US5998472 Enhanced flexibility of polymeric film on mammalian skin |
| 12/07/1999 | US5998470 Osteoporosis; oral diseases; antiarthritic agents |
| 12/07/1999 | US5998469 Nervous system diosrders; autoimmune diseases; antiinflammatory agents |
| 12/07/1999 | US5998467 Glaucoma, intraocular hypertension |
| 12/07/1999 | US5998465 Reduce tissue damage; antiinflammatory agents; oxidation resistance |
| 12/07/1999 | US5998460 Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof |
| 12/07/1999 | US5998459 Incotinence therapy |
| 12/07/1999 | US5998458 Administering inotropic agent and adrenergic receptor antagonist |
| 12/07/1999 | US5998457 Creatine analogues for treatment of obesity |
| 12/07/1999 | US5998454 Antiinflammatory agent; eyes |
| 12/07/1999 | US5998453 Antiinflammatory agents |
| 12/07/1999 | US5998452 Benzene derivatives, compositions and methods for treating ischemic diseases |
| 12/07/1999 | US5998449 Malaria |
| 12/07/1999 | US5998448 Combined preparations with vascular effect containing dihydropyridines acetylsalicylic acid nitroesters and vitamins |
| 12/07/1999 | US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 12/07/1999 | US5998445 Peptic ulcers |
| 12/07/1999 | US5998443 Phosphorous containing benzothiophenes for treating estrogen deficiency |
| 12/07/1999 | US5998442 Benzo [B] thiophene compounds, and compositions for treating bone loss, and hyperlipidemia |
| 12/07/1999 | US5998441 Benzothiophene compounds, intermediates, compositions, and methods |
| 12/07/1999 | US5998436 Pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient |
| 12/07/1999 | US5998435 Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis |
| 12/07/1999 | US5998434 Composition for treating pain |
| 12/07/1999 | US5998431 Sustained-release matrices for dental application |
| 12/07/1999 | US5998430 Bladder and urinary system disorders |
| 12/07/1999 | US5998429 Azabicyclic esters of carbamic acids useful in therapy |
| 12/07/1999 | US5998428 Antiinflammatory agent; side effect reduction |
| 12/07/1999 | US5998426 9,10 disubstituted camptothecin derivatives with antitumor activity |
| 12/07/1999 | US5998425 Cytokine antagonist; antiarthritic agent |
| 12/07/1999 | US5998423 Methods for modulating melanin production |
| 12/07/1999 | US5998422 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |